Rick A Weideman
Overview
Explore the profile of Rick A Weideman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banerjee S, Weideman R, Jacob D, DiGregorio H, Kelly K, Banerjee A, et al.
JACC Adv
. 2025 Jan;
4(1):101459.
PMID: 39759440
Background: Estimation of long-term risk for cardiovascular events using the SMART (Secondary Manifestations of Arterial Disease) risk score can be potentially valuable in devising risk mitigation strategies. Objectives: The objective...
2.
Hopper R, McMahan D, Jarvis K, Weideman R
J Pharm Pract
. 2024 Jan;
37(5):1127-1131.
PMID: 38241151
There has been concern over whether to use sodium-glucose-cotransporter-2 (SGLT-2) inhibitors in patients that use catheters due to the concern for increased urinary tract infections (UTIs). The concern is that...
3.
E Stopschinski B, Weideman R, McMahan D, Jacob D, Little B, Chiang H, et al.
Ther Adv Neurol Disord
. 2023 Mar;
16:17562864231156674.
PMID: 36875711
Alzheimer's disease (AD) is an untreatable cause of dementia, and new therapeutic approaches are urgently needed. AD pathology is defined by extracellular amyloid plaques and intracellular neurofibrillary tangles. Research of...
4.
Vazirian S, Ho T, Weideman R, Salinas M, Hurd P, Stuve O
J Cent Nerv Syst Dis
. 2022 Jul;
14:11795735221113102.
PMID: 35860714
Background: Recent data indicate that the three-month prevalence of severe headaches or migraines in the US general population is close to 25%. Participation of primary care providers will therefore be...
5.
Pham T, Butler A, Weideman R, Annaswamy T
Am J Phys Med Rehabil
. 2021 Jun;
101(4):341-347.
PMID: 34121069
Objective: Our objectives were to explore the association between phosphodiesterase 5 inhibitor use and lumbar decompression surgery by evaluating the prevalence of lumbar decompression surgery in a treatment group of...
6.
Stuve O, Weideman R, McMahan D, Jacob D, Little B
Ther Adv Neurol Disord
. 2020 Jul;
13:1756286420935676.
PMID: 32647537
Background: Our aim was to determine whether specific nonsteroidal anti-inflammatory (NSAID) agents are associated with a decreased frequency of Alzheimer's disease (AD). Materials And Methods: Days of drug exposure were...
7.
Phan H, Weideman R, Cipher D, Feagins L
Intest Res
. 2020 Apr;
18(3):282-288.
PMID: 32252501
Background/aims: Safety for tumor necrosis factor inhibitors (TNFi) in cancer has been focused on risk of incident malignancies, but studies on prognostic effects have been scarce. We determined survival and...
8.
Runeberg H, Higbea A, Weideman R, Alvarez C
J Pharm Pract
. 2020 Jan;
34(5):715-720.
PMID: 31955662
Background: Studies have shown an association between metformin use and vitamin B deficiency. Since 2017, the American Diabetes Association (ADA) has included a recommendation for periodic vitamin B measurements in...
9.
Bou Dargham B, Baskar A, Tejani I, Cui Z, Chauhan S, Sum-Ping J, et al.
Cardiovasc Revasc Med
. 2018 Dec;
20(9):805-811.
PMID: 30579773
Background: The effect of perioperative bridging therapy on risks of ischemic cardiac events and major bleeding complications in patients on dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) remains...
10.
Feagins L, Weideman R
Dig Dis Sci
. 2018 Apr;
63(7):1675-1677.
PMID: 29671162
No abstract available.